Amylin‐amide: a new bone‐conserving peptide from the pancreas
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Amylin‐amide is a new member of the family of peptides encoded by the calcitonin multigene complex. In the present study, we have compared directly, the hypocalcaemic potency and duration of action of human amylin‐amide and human calcitonin in an in vivo rat bioassay and an in vitro osteoclast bone resorption assay. Amylin‐amide was found to have a potency approximately 40‐fold lower than human calcitonin, whilst both peptides followed the same time course. This suggests that amylin‐amide is the most potent non‐calcitonin hypocalcaemic peptide so far reported. An important physiological implication follows. It would seem that amylin‐amide can play a central role in the maintenance of the skeleton by virtue of its inhibitory influence on osteoclastic function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Early studies have found that, similar to calcitonin and CGRP, injection of amylin strongly induced hypocalcemia with a potency that was either equal or lower than that of calcitonin (59, 77, 138, 220, 228).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [228]
Citations
Cites
NORMAN, A. W., ROTH, J., & ORCI, L. (1982) · Endocrine Reviews · doi:10.1210/edrv-3-4-331 · Cited by 703
Westermark, P., Wernstedt, C., Wilander, E., & Sletten, K. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)90708-4 · Cited by 512
ISLET AMYLOID FORMED FROM DIABETES-ASSOCIATED PEPTIDE MAY BE PATHOGENIC IN TYPE-2 DIABETES
Clark, A., Lewis, C. E., Willis, A. C., Cooper, G. J. S., Morris, J. F., Reid, K. B. M., & Turner, R. C. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90825-7 · Cited by 350
Westermark, P., Wilander, E., Westermark, G. T., & Johnson, K. H. (1987) · Diabetologia · doi:10.1007/bf00274799 · Cited by 208
Peptides from the calcitonin genes: molecular genetics, structure and function
Breimer, L. H., MacIntyre, I., & Zaidi, M. (1988) · Biochemical Journal · doi:10.1042/bj2550377 · Cited by 189
Self-citationRat amylin: cloning and tissue-specific expression in pancreatic islets.
Leffert, J. D., Newgard, C. B., Okamoto, H., Milburn, J. L., & Luskey, K. L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.9.3127 · Cited by 121
EFFECTS OF PEPTIDES FROM THE CALCITONIN GENES ON BONE AND BONE CELLS
Zaidi, M., Bevis, P. J. R., Beacham, J. L., MacIntyre, I., Chambers, T. J., & Gaines Das, R. E. (1988) · Quarterly Journal of Experimental Physiology · doi:10.1113/expphysiol.1988.sp003168 · Cited by 87
Self-citationOsteoporosis and calcitonin deficiency.
Stevenson, J., White, M. C., Joplin, G. F., & MacIntyre, I. M. (1982) · BMJ · doi:10.1136/bmj.285.6347.1010 · Cited by 27
Self-citation
Cited by
Islet Amyloid Polypeptide, Islet Amyloid, and Diabetes Mellitus
Westermark, P., Andersson, A., & Westermark, G. T. (2011) · Physiological Reviews · doi:10.1152/physrev.00042.2009 · Cited by 1,044
“The structural similarity of IAPP to calcitonin immediately created interest in the possibility that IAPP may be involved in the regulation of calcified tissues (222), and experimentally it was shown that the peptide inhibits osteoclastic activity (437).”
BackgroundGlucose-dependent insulinotropic polypeptide receptor knockout mice have altered bone turnover
Xie, D., Cheng, H., Hamrick, M., Zhong, Q., Ding, K.-H., Correa, D., Williams, S., Mulloy, A., Bollag, W., Bollag, R. J., et al. (2005) · Bone · doi:10.1016/j.bone.2005.06.021 · Cited by 171
The Activity of Peptides of the Calcitonin Family in Bone
Naot, D., Musson, D. S., & Cornish, J. (2019) · Physiological Reviews · doi:10.1152/physrev.00066.2017 · Cited by 141
“Early studies have found that, similar to calcitonin and CGRP, injection of amylin strongly induced hypocalcemia with a potency that was either equal or lower than that of calcitonin (59, 77, 138, 220, 228).”
BackgroundPreclinical pharmacology of pramlintide in the rat: Comparisons with human and rat amylin
Young, A. A., Vine, W., Gedulin, B. R., Pittner, R., Janes, S., Gaeta, L. S. L., Percy, A., Moore, C. X., Koda, J. E., Rink, T. J., et al. (1996) · Drug Development Research · doi:10.1002/(sici)1098-2299(199604)37:4<231::aid-ddr5>3.0.co;2-m · Cited by 135
O'Brien, T. D., Butler, P. C., Westermark, P., & Johnson, K. H. (1993) · Veterinary Pathology · doi:10.1177/030098589303000401 · Cited by 115
Diabetes pharmacotherapy and effects on the musculoskeletal system
Kalaitzoglou, E., Fowlkes, J. L., Popescu, I., & Thrailkill, K. M. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3100 · Cited by 100
Amylin inhibits bone resorption by a direct effect on the motility of rat osteoclasts
Alam, A., Moonga, B., Bevis, P., Huang, C., & Zaidi, M. (1993) · Experimental Physiology · doi:10.1113/expphysiol.1993.sp003679 · Cited by 99
Self-citationFox, N., Schrementi, J., Nishi, M., Ohagi, S., Chan, S. J., Heisserman, J. A., Westermark, G. T., Leckström, A., Westermark, P., & Steiner, D. F. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81444-5 · Cited by 89
Albrandt, K., Brady, E. M., Moore, C. X., Mull, E., Sierzega, M. E., & Beaumont, K. (1995) · Endocrinology · doi:10.1210/endo.136.12.7588285 · Cited by 88
The Calcitonin Gene Peptides: Biology and Clinical Relevance
Zaidi, M., Moonga, B. S., Bevis, P. J. R., Bascal, Z. A., & Breimer, L. H. (1990) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408369009105900 · Cited by 91
Self-citationCalcitonin and Bone Physiology: In Vitro, In Vivo, and Clinical Investigations
Xie, J., Guo, J., Kanwal, Z., Wu, M., Lv, X., Ibrahim, N. A., Li, P., Buabeid, M. A., Arafa, E. A., & Sun, Q. (2020) · International Journal of Endocrinology · doi:10.1155/2020/3236828 · Cited by 83
Amylin injection causes elevated plasma lactate and glucose in the rat
Young, A. A., Wang, M.-W., & Cooper, G. J. S. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)81113-m · Cited by 71
Protein aggregates and proteostasis in aging: Amylin and β-cell function
Press, M., Jung, T., König, J., Grune, T., & Höhn, A. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.03.010 · Cited by 72
Islet amyloid polypeptide is expressed in endocrine cells of the gastric mucosa in the rat and mouse
Mulder, H., Lindh, A.-C., Ekblad, E., Westermark, P., & Sundler, F. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90118-x · Cited by 56
CELLULAR BIOLOGY OF BONE RESORPTION
Zaidi, M., Alam, A. S. M. T., Shankar, V. S., Bax, B. E., Bax, C. M. R., Moonga, B. S., Bevis, P. J. R., STEVENS, C., Blake, D. R., Pazianas, M., et al. (1993) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/j.1469-185x.1993.tb00996.x · Cited by 67
Self-citationCellular and Molecular Mechanisms in the Regulation and Function of Osteoclasts
Chambers, T. J., & Hall, T. J. (1991) · Vitamins and hormones · doi:10.1016/s0083-6729(08)60682-2 · Cited by 66
Calcium sensing and cell signaling processes in the local regulation of osteoclastic bone resorption
Zaidi, M., Moonga, B. S., & Huang, C. L.-H. (2004) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1017/s1464793103006262 · Cited by 51
“The latter would be accompanied by separate cellular changes with each driven by changes in cellular levels of the different intracellular second messengers cAMP and Ca2+, respectively, whilst not excluding synergisms between the two systems (Zaidi et al., 1990 c).”
BackgroundSelf-citationEffects of Amylin on Human Osteoblast-Like Cells
Villa, I., Rubinacci, A., Ravasi, F., Ferrara, A. F., & Guidobono, F. (1997) · Peptides · doi:10.1016/s0196-9781(97)00056-9 · Cited by 45
Osteoclast function and its control
Zaidi, M., Pazianas, M., Shankar, V., Bax, B. E., Bax, C. M. R., Bevis, P. J. R., Stevens, C. R., Huang, C. L.-H., Blake, D., Moonga, B., et al. (1993) · Experimental Physiology · doi:10.1113/expphysiol.1993.sp003721 · Cited by 54
Self-citationMechanism of action of amylin in bone
Tamura, T., Miyaura, C., Owan, I., & Suda, T. (1992) · Journal of Cellular Physiology · doi:10.1002/jcp.1041530103 · Cited by 42
Islet amyloid: An enigma of type 2 diabetes
Clark, A. (1992) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610080204 · Cited by 38
Human Amylin: From Pathology to Physiology and Pharmacology
Ling, W., Huang, Y., Qiao, Y.-C., Zhang, X., & Zhao, H. (2019) · Current Protein and Peptide Science · doi:10.2174/1389203720666190328111833 · Cited by 38
Amylin increases bone volume but cannot ameliorate diabetic osteopenia
Romero, D. F., Bryer, H. P., Rucinski, B., Isserow, J. A., Buchinsky, F. J., Cvetković, M., Liu, C. C., & Epstein, S. (1995) · Calcified Tissue International · doi:10.1007/bf00298745 · Cited by 35
“Both amylin and CGRP inhibit osteoclast motility (quiescent or Q-effect) without producing cell retraction (Reffect) in contrast to calcitonin that produces both effects [10, 42-44].”
BackgroundInfluentialAmylin in the Periphery II: An Updated Mini-Review
Wookey, P. J., Lutz, T. A., & Andrikopoulos, S. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.263 · Cited by 32
Amylin in bone conservation current evidence and hypothetical Considerations
Zaidi, M., Shankar, V. S., Huang, C. L.-H., Pazianas, M., & Bloom, S. R. (1993) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(93)90095-v · Cited by 30
Self-citationChakraborty, S., Chatterjee, B., & Basu, S. (2012) · Biophysical Chemistry · doi:10.1016/j.bpc.2012.05.003 · Cited by 29
Kinins and Neuro-osteogenic Factors
Lerner, U. H., Persson, E., & Lundberg, P. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00063-x · Cited by 31
Wimalawansa, S. J. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb22758.x · Cited by 28
Self-citationWookey, P. J., Cao, Z., & Cooper, M. E. (1998) · Mineral and Electrolyte Metabolism · doi:10.1159/000057400 · Cited by 28
Expression and Function of the Calcitonin Gene Products
Zaidi, M., Moonga, B. S., Bevis, P. J. R., Alam, A. S. M. T., Legon, S., Wimalawansa, S. J., MacIntyre, I., & Breimer, L. H. (1991) · Vitamins and hormones · doi:10.1016/s0083-6729(08)60683-4 · Cited by 28
Self-citationSilvestre, R. A., Salas, M., Dégano, P., Peiró, E., & Marco, J. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90209-f · Cited by 24
D’Este, L., Wimalawansa, S. J., & RENDA, T. G. (1995) · Archivum histologicum japonicum · doi:10.1679/aohc.58.537 · Cited by 21
Self-citationVine, W., Beaumont, K. C., Gedulin, B. R., Pittner, R. A., Moore, C. X., RINK, T. J., & Young, A. A. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00544-4 · Cited by 19
Rapid publication: Hypocalcemic actions of amylin amide in humans
Wimalawansa, S. J., Gunasekera, R. D., & Datta, H. K. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070915 · Cited by 18
Self-citationIslet amyloid polypeptide (amylin) increases the renal excretion of calcium in the conscious dog
Miles, P. D. G., Deftos, L. J., Moossa, A. R., & Olefsky, J. M. (1994) · Calcified Tissue International · doi:10.1007/bf00310405 · Cited by 17
“This hypocalcemic effect of the peptide has also been observed in the rat [25], rabbit [26], and human [27].”
BackgroundInfluentialAMYLIN: PHYSIOLOGICAL ROLES IN THE KIDNEY AND A HYPOTHESIS FOR ITS ROLE IN HYPERTENSION
Wookey, P. J., & Cooper, M. E. (1998) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1998.tb02272.x · Cited by 17
Kikumoto, K., Katafuchi, T., & Minamino, N. (2003) · Hypertension Research · doi:10.1291/hypres.26.s15 · Cited by 14
“As major physiological effects of AMY, inhibition of osteoclast-mediated bone resorption and suppression of appetite have been reported (29, 30).”
BackgroundJordan, K., O’Brien, T. D., & Johnson, K. H. (1994) · Amyloid · doi:10.3109/13506129409148447 · Cited by 11
Jacques, D., Dumont, Y., van Rossum, D., & Quirion, R. (2000) · Handbook of chemical neuroanatomy · doi:10.1016/s0924-8196(00)80010-x · Cited by 16
Wookey, P. J., Xuereb, L., Tikellis, C., & Cooper, M. E. (2003) · The Scientific World JOURNAL · doi:10.1100/tsw.2003.17 · Cited by 13
Section Review Oncologic, Endocrine & Metabolic: The amylin, CGRP and calcitonin family of peptides
Beeley, N. R. A., & Prickett, K. S. (1996) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.6.6.555 · Cited by 10
Young, A. (2005) · Advances in pharmacology · doi:10.1016/s1054-3589(05)52016-7 · Cited by 8
Metabolic effects of amylin in lactating goats.
Min, S. H., Farr, V. C., Lee, J., Prosser, C. G., Cooper, G. J. S., & Davis, S. R. (1999) · Journal of Animal Science · doi:10.2527/1999.7751241x · Cited by 8
Pagani, F., Netti, C., GUIDOBONO, F., Lattuada, N., Ticozzi, C., & Sibilia, V. (1998) · Neuroendocrinology · doi:10.1159/000054369 · Cited by 7
Effects of amylin on bone development and egg production in hens
Güzel, S., Gunes, N., Yıldız, H., & Yılmaz, B. (2009) · Poultry Science · doi:10.3382/ps.2008-00256 · Cited by 6
Kinins and Neuro-osteogenic Factors
Lerner, U. H., & Lundberg, P. (2002) · Elsevier eBooks · doi:10.1016/b978-012098652-1.50146-3 · Cited by 18
Purification and Biological Function of Caldecrin
Tomomura, A., Bandow, K., & Tomomura, M. (2021) · Medicines · doi:10.3390/medicines8080041 · Cited by 4
“Glucagon [2,3], amylin [4,5], and calcitonin gene-related peptides [6,7] secreted from the pancreas may be responsible for hypocalcemia.”
BackgroundPhysiological and Pathophysiological Role of Islet Amyloid Polypeptide (IAPP, Amylin)
Westermark, G. T. (2011) · Springer eBooks · doi:10.1007/978-1-4419-6956-9_15 · Cited by 4
“Bone absorption is reduced because IAPP slows down the mobility of the osteoclasts [106–108] and prevents the fusion of the preosteoclasts into multinucleated osteoclasts shown in rodent cell culture [109].”
BackgroundAmylin and Related Proteins: Physiology and Pathophysiology
Cooper, G. J. S. (2001) · Comprehensive physiology · doi:10.1002/cphy.cp070210 · Cited by 7
Caldecrin: A pancreas-derived hypocalcemic factor, regulates osteoclast formation and function
Tomomura, M., & Tomomura, A. (2015) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v6.i4.358 · Cited by 4
Naot, D., Musson, D. S., & Cornish, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00033-6 · Cited by 4
Amylin and Calcitonin Gene-Related Peptide
Naot, D., Reid, I. R., & Cornish, J. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00056-2 · Cited by 2
Genetics and Cell Biology of Calcitonin Action
Zaidi, M., Moonga, B. S., Pazianas, M., Shankar, V. S., & Huang, C. L.-H. (1997) · Principles of medical biology · doi:10.1016/s1569-2582(97)80173-0 · Cited by 2
Self-citationOverview: Inhibitors of Bone Resorption and Implications for Therapy
Zaidi, M., Alam, A. T., Shankar, V. S., Fairburn, K., Huang, C. L.-H., Moonga, B. S., Panetta, J., Blake, D. R., & Pazianas, M. (1992) · Current Opinion on Therapeutic Patents · doi:10.1517/13543776.2.10.1517 · Cited by 2
Self-citationMulder, H., Åhrén, B., Ekblad, E., Gebré‐Medhin, S., Betsholtz, C., Sundelin, J., Westermark, G. T., Westermark, P., & Sundler, F. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-695-9_21 · Cited by 1
The role of amylin in the development of diabetic osteopathy
Сафарова, С. С. (2017) · Kazan medical journal · doi:10.17750/kmj2017-813 · Cited by 1
Molecular Pharmacology of Antiresorptive Therapy for Osteoporosis
Adebanjo, O. A., Schwab, E., Sun, L., Pazianas, M., Moonga, B. S., & Zaidi, M. (1998) · Advances in organ biology · doi:10.1016/s1569-2590(08)60153-6 · Cited by 1
Self-citationAmilina: del estudio molecular a las acciones fisiológicas
Rojas, I., & Novials, A. (2001) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(01)74399-9 · Cited by 6
Amylin and Calcitonin Gene-Related Peptide
Reid, I. R., & Cornish, J. (2002) · Elsevier eBooks · doi:10.1016/b978-012098652-1.50138-4
Metadata
- Authors
- Zaidi, M., Datta, H., Bevis, P., Wimalawansa, S., & MacIntyre, I.
- Affiliations
- Hammersmith Hospital (GB)
- ORCID
- Venue
- Experimental Physiology
- Publisher
- Wiley
- Published
- 1990-07
- Volume
- 75
- Issue
- 4
- Pages
- 529-536
- ISSN
- 0958-0670 (ISSN-L)
- 1469-445X
- OpenAlex
- W1986482329
- Semantic Scholar
- 94ac03622cdd2fb47b6f217175607d5e9afa516b
- Cited by
- 61
- References
- 8
- Citations by year
- 2021: 1 · 2020: 1 · 2019: 2 · 2018: 3 · 2017: 1 · 2015: 1 · 2012: 2
- FWCI
- 2.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Experimental Physiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Keywords
- calcitonin, calcitonin gene-related peptide, osteoclast resorption, bone preservation, pancreatic peptides
- MeSH terms
- Amyloid, Animals, Bone Resorption, Calcium, Humans, Magnesium, Male, Pancreas, Rats, Inbred Strains, Serum Albumin, Rats, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.